Agilent completes acquisition of Proscia
A•Agilent completed its acquisition of Proscia for $240 million in cash at closing, with up to $30 million in additional payments tied to future performance milestones.
1. Deal completed
Agilent completed its previously announced acquisition of digital pathology software provider Proscia for $240 million in cash at closing. The deal includes up to $30 million in additional payments tied to future performance milestones. Proscia joins Agilent’s Life Sciences and Diagnostics Markets Group, combining its software platform with Agilent’s pathology instrumentation and reagents to support AI-enabled diagnostics and drug discovery.
